Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Poirier and colleagues have developed a system for in vivo genome editing of patient-derived xenografts using inducible CRISPR-Cas9 and demonstrate applications for modeling gene dependencies and drug resistance.
